|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09997 KANGJI MEDICAL
Nominal 
5.910 -0.040 (-0.672%) | 2021/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | 2017/12 RMB(K¥) | |
| Turnover | 690,263 | 34.951% | 511,490 | 503,467 | 353,670 | 247,506 |
| Cost of Sales | (127,337) | 59.131% | (80,020) | (80,292) | (64,373) | (47,801) |
| Gross Profit | 562,926 | 30.467% | 431,470 | 423,175 | 289,297 | 199,705 |
| 2021/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | 2017/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (614) | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 534,497 | 72.377% | 310,075 | 391,194 | 261,159 | 162,172 | |
| Taxation | (77,708) | 52.593% | (50,925) | (64,459) | (37,366) | (23,695) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | (8,854) | (120,291) | (77,092) | (20,772) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 456,789 | 82.500% | 250,296 | 206,444 | 146,701 | 117,705 | |
| 2021/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | 2017/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (33,092) | 181.994% | (11,735) | (12,560) | (6,956) | (1,166) |
| Depreciation & Amortisation | 11,860 | 44.564% | 8,204 | 6,845 | 6,261 | 6,473 |
| Directors' Emoluments | 7,756 | -5.461% | 8,204 | 867 | 631 | 480 |
| 2021/12 - Final | %Chg (Compare to Final) | 2020/12 | 2019/12 | 2018/12 | 2017/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2021/12 - Final | %Chg (Compare to Final) | 2020/12 | 2019/12 | 2018/12 | 2017/12 | |
| EPS (cts) | 37.310 | 42.025% | 26.270 | 20.110 | -- | -- |
| DPS (cts) | 14.610 | -- | 3.702 | -- | -- | -- |
| Dividend Payout Ratio (%) | 39.158% | -- | 14.093% | -- | -- | -- |
| Cash flow per share ($) | 0.356 | -- | 0.232 | 0.317 | -- | -- |
| NBV per share ($) | 2.617 | -- | 2.345 | -- | -- | -- |
| Remarks: | Real time quote last updated: 14/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 285,847,000 |
| %Change | 11.895% |
| EPS / (LPS) | RMB 0.244 |
| NBV Per Share (¥) | RMB 1.945 |